[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes ; day:14 ; month:12 ; year:2022 ; pages:1-13
European journal of nuclear medicine and molecular imaging ; (14.12.2022), 1-13

Creator
Santillo, Alexander F.
Leuzy, Antoine
Honer, Michael
Landqvist Waldö, Maria
Tideman, Pontus
Harper, Luke
Ohlsson, Tomas
Moes, Svenja
Giannini, Lucia
Jögi, Jonas
Groot, Colin
Ossenkoppele, Rik
Strandberg, Olof
Swieten, John van
Smith, Ruben
Hansson, Oskar
Contributor
SpringerLink (Online service)

DOI
10.1007/s00259-022-06065-4
URN
urn:nbn:de:101:1-2023022321014333256446
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Santillo, Alexander F.
  • Leuzy, Antoine
  • Honer, Michael
  • Landqvist Waldö, Maria
  • Tideman, Pontus
  • Harper, Luke
  • Ohlsson, Tomas
  • Moes, Svenja
  • Giannini, Lucia
  • Jögi, Jonas
  • Groot, Colin
  • Ossenkoppele, Rik
  • Strandberg, Olof
  • Swieten, John van
  • Smith, Ruben
  • Hansson, Oskar
  • SpringerLink (Online service)

Other Objects (12)

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

External validation of a 3-step falls prediction model in mild Parkinson’s disease

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Towards a unified protocol for handling of CSF before β-amyloid measurements

Towards a unified protocol for handling of CSF before β-amyloid measurements

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Novel insights regarding the measurement properties of the SCOPA-AUT

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Related objects